MST1 and Huntington disease: Additionally, there is a concomitant decrease in nuclear YAP in HD (Fig. 1) suggesting that activation of MST1/2 upstream of YAP may lead to alterations in YAP levels and nuclear localization and thereby provide a new target for therapy.